Icosagen Cell Factory
Research organisation
Icosagen Cell Factory
Description
Icosagen is a research-driven contract research provider for biopharmaceutical and biotechnology industries that deftly adapts to market forces and current trends, and is always guided by the needs of its customers.
The Group comprises four entities: parent company Icosagen AS and three subsidiaries: Icosagen Cell Factory OÜ, Icosagen Technologies Inc., and IcoPark OÜ.
The Group comprises four entities: parent company Icosagen AS and three subsidiaries: Icosagen Cell Factory OÜ, Icosagen Technologies Inc., and IcoPark OÜ.
Icosagen Cell Factory
Address
Eerika tee 1, Õssu, Kambja 61713
Kambja, Tartu county, Estonia
Kambja, Tartu county, Estonia
Contact
info@icosagen.com / lauri.peil@icosagen.com
Description
Icosagen is a research-driven contract research provider for biopharmaceutical and biotechnology industries that deftly adapts to market forces and current trends, and is always guided by the needs of its customers.
The Group comprises four entities: parent company Icosagen AS and three subsidiaries: Icosagen Cell Factory OÜ, Icosagen Technologies Inc., and IcoPark OÜ.
The Group comprises four entities: parent company Icosagen AS and three subsidiaries: Icosagen Cell Factory OÜ, Icosagen Technologies Inc., and IcoPark OÜ.
Matchmaking
Connect with Icosagen Cell Factory
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways